Deaths Involving MDMA and the Concomitant Use of Pharmaceutical Drugs

Author： Pilgrim J.L.  

Publisher： Oxford University Press

ISSN： 0146-4760

Source： Journal of Analytical Toxicology, Vol.35, Iss.4, 2011-05, pp. : 219-226

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

CASE REPORT: Fatality Due To Combined Use of the Designer Drugs MDMA and PMA: A Distribution Study

By Dams R.  

Journal of Analytical Toxicology, Vol. 27, Iss. 5, 2003-07 ,pp. : 318-322

Oxford University Press

Access to resources Recommend Favorite

Deaths Involving 1,1-Difluoroethane at the San Diego County Medical Examiner's Office

By Vance Chris   Swalwell Christopher   McIntyre Iain M.  

Journal of Analytical Toxicology, Vol. 36, Iss. 9, 2012-11 ,pp. : 626-633

Oxford University Press

Access to resources Recommend Favorite

Sustainable use of biodiversity by the pharmaceutical industry?

By Gebhardt Martina  

International Journal of Sustainable Development, Vol. 1, Iss. 1, 2004-05 ,pp. : 63-72

Inderscience Publishers

Access to resources Recommend Favorite

Investigation of the First Deaths in the United Kingdom Involving the Detection and Quantitation of the Piperazines BZP and 3-TFMPP

By Elliott Simon   Smith Christopher  

Journal of Analytical Toxicology, Vol. 32, Iss. 2, 2008-03 ,pp. : 172-177

Oxford University Press

Access to resources Recommend Favorite

CASE REPORT: Two Deaths Attributed to the Use of 2,4-Dinitrophenol

By Miranda Estuardo J.  

Journal of Analytical Toxicology, Vol. 30, Iss. 3, 2006-04 ,pp. : 219-222

Oxford University Press

Access to resources Recommend Favorite